Skip to Main Content

Insmed, Inc.

INSM Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Income
Balance Sheet
Cash Flow
INSM Income Statement
INSM Balance Sheet
INSM Cash Flow
INSM Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
INSM Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
INSM Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by INSM's directors and management

Government lobbying spending instances

  • $50,000 Apr 18, 2019 Issue: Health Issues
  • $50,000 Jan 18, 2019 Issue: Health Issues
  • $50,000 Oct 16, 2018 Issue: Health Issues
  • $50,000 Jul 19, 2018 Issue: Health Issues
  • $50,000 Apr 19, 2018 Issue: Health Issues
  • $22,500 Jul 20, 2011 Issue: Pharmacy
  • $22,500 Apr 11, 2011 Issue: Pharmacy
  • $22,500 Jan 17, 2011 Issue: Pharmacy
  • $22,500 Oct 12, 2010 Issue: Pharmacy
  • $22,500 Jul 20, 2010 Issue: Pharmacy
  • $22,500 May 27, 2010 Issue: Pharmacy
  • $22,500 Jan 14, 2010 Issue: Pharmacy
  • $22,500 Oct 20, 2009 Issue: Pharmacy
  • $22,500 Jul 15, 2009 Issue: Pharmacy
  • $22,500 Jul 15, 2009 Issue: Pharmacy
  • $22,500 Oct 31, 2008 Issue: Pharmacy
  • $22,500 Jul 08, 2008 Issue: Pharmacy
  • $22,500 Apr 15, 2008 Issue: Pharmacy
  • $22,500 Apr 13, 2008 Issue: Pharmacy
  • $140,000 Feb 01, 2007 Issue: Health Issues
  • $160,000 Aug 08, 2006 Issue: Health Issues
  • $40,000 Feb 13, 2006 Issue: Health Issues

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Deimmunized lysostaphin and methods of use Oct. 01, 2024
  • Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Jun. 25, 2024
  • Patent Title: Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating lupus nephritis Jun. 04, 2024
  • Patent Title: Lipo-glycopeptide cleavable derivatives and uses thereof Jan. 02, 2024
  • Patent Title: Prostacyclin compounds, compositions and methods of use thereof Oct. 24, 2023
  • Patent Title: Dry powder compositions of treprostinil prodrugs and methods of use thereof Sep. 19, 2023
  • Patent Title: Antibodies and methods of making same May. 16, 2023
  • Patent Title: Methods for continuous manufacture of liposomal drug products Feb. 07, 2023
  • Patent Title: Dry powder compositions of treprostinil prodrugs and methods of use thereof Oct. 04, 2022
  • Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Sep. 20, 2022
  • Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Jul. 26, 2022
  • Patent Title: Methods of manufacturing treprostinil and treprostinil derivative prodrugs Oct. 19, 2021
  • Patent Title: Lipo-glycopeptide cleavable derivatives and uses thereof Jul. 27, 2021
  • Patent Title: Prostacyclin compounds, compositions and methods of use thereof May. 04, 2021
  • Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Nov. 10, 2020
  • Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Aug. 25, 2020
  • Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Mar. 17, 2020
  • Patent Title: Prostacyclin compounds, compositions and methods of use thereof Jan. 07, 2020
  • Patent Title: Stabilized vancomycin formulations Nov. 12, 2019
  • Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Sep. 03, 2019
  • Patent Title: Methods of manufacturing treprostinil and treprostinil derivative prodrugs Jul. 09, 2019
  • Patent Title: Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Jun. 25, 2019
  • Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Apr. 09, 2019
  • Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Mar. 26, 2019
  • Patent Title: Stabilized vancomycin formulations Nov. 13, 2018
  • Patent Title: Methods of treating pulmonary disorders with liposomal amikacin formulations Sep. 04, 2018
  • Patent Title: Prostacyclin compounds, compositions and methods of use thereof Jul. 03, 2018
  • Patent Title: Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods of use thereof Mar. 27, 2018
  • Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Feb. 20, 2018
  • Patent Title: Sustained release of antiinfectives Nov. 28, 2017
  • Patent Title: Method of treating pulmonary disorders with liposomal amikacin formulations Aug. 22, 2017
  • Patent Title: Methods of treating pulmonary disorders with liposomal amikacin formulations Aug. 08, 2017
  • Patent Title: Systems for treating pulmonary infections Feb. 14, 2017
  • Patent Title: Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Jan. 24, 2017
  • Patent Title: Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Jan. 24, 2017
  • Patent Title: Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Dec. 06, 2016
  • Patent Title: Prostacyclin compounds, compositions and methods of use thereof Oct. 18, 2016
  • Patent Title: Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Aug. 02, 2016
  • Patent Title: Method for treating pulmonary disorders with liposomal amikacin formulations May. 10, 2016
  • Patent Title: Prostacyclin compounds, compositions and methods of use thereof Feb. 09, 2016
  • Patent Title: Platinum aggregates and process for producing the same Nov. 17, 2015
  • Patent Title: Method of treating pulmonary disorders with liposomal amikacin formulations Sep. 01, 2015
  • Patent Title: Methods of treating pulmonary disorders with liposomal amikacin formulations Aug. 25, 2015
  • Patent Title: Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally Aug. 18, 2015
  • Patent Title: Sustained release of antiinfectives Aug. 12, 2014
  • Patent Title: Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Mar. 25, 2014
  • Patent Title: Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Mar. 18, 2014
  • Patent Title: Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Mar. 18, 2014
  • Patent Title: Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Feb. 04, 2014
  • Patent Title: Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Jan. 21, 2014
Government Contracts

Estimated quarterly amount awarded from public contracts

WallStreetBets

Number of mentions of INSM in WallStreetBets Daily Discussion

INSM News

Recent insights relating to INSM

CNBC Recommendations

Recent picks made for INSM stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in INSM

INSM Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view INSM Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top